MedTrace Logo

Study to Evaluate the Effect of Gum Acacia (FibregumTM) on Post-prandial Glucose, Insulin Levels and Food Intake

NCT04515277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-08-19

No results posted yet for this study

Summary

Study to evaluate the effect of gum acacia (FibregumTM) on post-prandial glucose and insulin levels and food intake in normal-weight and overweight subjects during a 2-7 weeks intervention period. In addition, tolerability and safety of gum acacia (FibregumTM) will be assessed.

Conditions

Interventions

DIETARY_SUPPLEMENT

40 g Gum acacia (FibregumTM)

Applied in 300 mL of orange juice with breakfast (single use at visit)

DIETARY_SUPPLEMENT

20 g Gum acacia (FibregumTM)

Applied in 300 mL of orange juice with breakfast (single use at visit)

DIETARY_SUPPLEMENT

0 g Gum acacia (FibregumTM)

300 mL of orange juice with breakfast (single use at visit)

Sponsors & Collaborators

  • Analyze & Realize

    collaborator NETWORK

  • Nexira

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-28
Primary Completion
2019-09-27
Completion
2019-09-27

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04515277 on ClinicalTrials.gov